We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAS icon
226
Masco
MAS
$16B
$8M 0.1%
173,594
+83,554
+93% +$3.22M
ECL icon
227
Ecolab
ECL
$75.6B
$7.97M 0.1%
27,503
+4,701
+21% +$874K
AAL icon
228
American Airlines Group
AAL
$9.58B
$7.94M 0.1%
244,604
-3,675
-1% -$119K
RARE icon
229
Ultragenyx Pharmaceutical
RARE
$2.65B
$7.93M 0.1%
125,500
+10,000
+9% +$636K
EXC icon
230
Exelon
EXC
$48.6B
$7.9M 0.1%
232,021
-82,216
-26% -$2.9M
ADP icon
231
Automatic Data Processing
ADP
$100B
$7.89M 0.1%
47,939
-14,871
-24% -$2.42M
TIF
232
DELISTED
Tiffany & Co.
TIF
$7.71M 0.1%
82,737
+34,210
+70% +$3.4M
CTMX icon
233
CytomX Therapeutics
CTMX
$705M
$7.68M 0.1%
687,833
+19,000
+3% +$199K
SRE icon
234
Sempra
SRE
$60.8B
$7.68M 0.1%
112,186
+40,196
+56% +$2.64M
BAX icon
235
Baxter International
BAX
$11.6B
$7.67M 0.1%
74,046
+25,154
+51% +$1.95M
DD icon
236
DuPont de Nemours
DD
$18.6B
$7.57M 0.09%
80,706
-51,880
-39% -$6.19M
SPG icon
237
Simon Property Group
SPG
$74.5B
$7.52M 0.09%
39,268
+12,046
+44% +$2.07M
HOLX
238
DELISTED
Hologic
HOLX
$7.49M 0.09%
156,569
+84,328
+117% +$3.9M
RTX icon
239
RTX Corp
RTX
$287B
$7.46M 0.09%
+91,409
New +$7.64M
GPN icon
240
Global Payments
GPN
$22.1B
$7.43M 0.09%
46,585
+9,578
+26% +$1.42M
OKE icon
241
Oneok
OKE
$58.7B
$7.4M 0.09%
108,080
+22,648
+27% +$1.53M
RDUS
242
DELISTED
Radius Health, Inc.
RDUS
$7.37M 0.09%
304,025
B
243
Barrick Mining
B
$62.2B
$7.37M 0.09%
467,759
-10,341
-2% -$137K
CVS icon
244
CVS Health
CVS
$137B
$7.34M 0.09%
115,165
-39,710
-26% -$2.14M
CERN
245
DELISTED
Cerner Corp
CERN
$7.28M 0.09%
99,681
-49,625
-33% -$3.35M
HST icon
246
Host Hotels & Resorts
HST
$16.8B
$7.25M 0.09%
342,696
+152,052
+80% +$2.87M
CHRW icon
247
C.H. Robinson
CHRW
$22B
$7.22M 0.09%
86,025
+59,816
+228% +$5.03M
VEEV icon
248
Veeva Systems
VEEV
$30.3B
$7.22M 0.09%
44,742
-121
-0.3% -$17.6K
LEA icon
249
Lear
LEA
$7.19B
$7.21M 0.09%
51,984
-12,484
-19% -$1.75M
IYR icon
250
iShares US Real Estate ETF
IYR
$4.59B
$7.2M 0.09%
82,781
-356
-0.4% -$31.2K

Similar funds

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.